Welcome to Acidity Regulator Quarterly China Report-Q4 2022.
Citric acid industry:
2022 was a good year for China's citric acid business, the output and exports of which hit record high in the year and the price peaked in June, despite that there was a reverse starting from Aug., showing price dive and operation slowdown. In Q4, citric acid manufacturers were operating at loss.
Sodium gluconate (SG) industry:
The EI report of Anhui BBCA Biochemical's technical renovation project of 10,000 t/a sodium gluconate (SG) and 20,000 t/a L-alanine was released.
Malic acid industry
Huaheng Biotech (Stock code: 688639) proposed to issue stock to raise funds for the construction of the 50,000 t/a malic acid project.
In Q4 2022, the price of citric acids was on the slide; the quarterly average ex-works prices of monohydrate citric acid and anhydrous citric acid were about 61%–63% of that in Q3.
The USD/CNY exchange rate in this period is 6.9475, sourced from the People's Bank of China on 3 Jan., 2023. Except for special instructions, all prices involved in this period include VAT.
- China's buoyant citric acid market in 2022
- Huaheng Biotech to raise fund for 50,000 t/a malic acid project
- Anhui BBCA Biochemical's progress on sodium gluconate project
- Ex-works prices of acidity regulators in China, Q4 2022
- Citric acid market sputters in Q4
- Exports of acidity regulators and raw materials in China, Q3 2022
- Updates on Jilin Union's 150,000 t/a citric acid project
- Seven Stars accredited as Shandong's key leading enterprise in agricultural industrialisation
- RZBC Boyuan's 200,000 t/a citric acid project to be approved
- COFCO Biotech's revenue drops in first three quarters
- Jindan Tech reports revenue growth in first three quarters
- Liaoning Kingfa plotting 50,000 t/a L-lactic acid project
- Rentai New Material plans 450 t/a iron citrate project


